10,372 Shares in Bath & Body Works, Inc. (NYSE:BBWI) Purchased by Farringdon Capital Ltd.

Farringdon Capital Ltd. purchased a new stake in shares of Bath & Body Works, Inc. (NYSE:BBWI) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 10,372 shares of the company’s stock, valued at approximately $402,000.

Several other large investors have also recently added to or reduced their stakes in BBWI. Golden State Wealth Management LLC acquired a new stake in shares of Bath & Body Works during the 4th quarter valued at about $26,000. SRS Capital Advisors Inc. boosted its holdings in Bath & Body Works by 99.7% during the fourth quarter. SRS Capital Advisors Inc. now owns 659 shares of the company’s stock valued at $26,000 after purchasing an additional 329 shares in the last quarter. UMB Bank n.a. grew its stake in shares of Bath & Body Works by 58.8% in the 4th quarter. UMB Bank n.a. now owns 905 shares of the company’s stock valued at $35,000 after purchasing an additional 335 shares during the period. Lindbrook Capital LLC raised its holdings in shares of Bath & Body Works by 81.9% in the 4th quarter. Lindbrook Capital LLC now owns 957 shares of the company’s stock worth $37,000 after buying an additional 431 shares in the last quarter. Finally, Wilmington Savings Fund Society FSB bought a new position in shares of Bath & Body Works during the 3rd quarter worth approximately $39,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Analyst Ratings Changes

A number of analysts have weighed in on the company. Cowen reiterated a “buy” rating on shares of Bath & Body Works in a research report on Thursday, February 27th. Citigroup lowered their target price on shares of Bath & Body Works from $48.00 to $36.00 and set a “buy” rating on the stock in a report on Monday, April 7th. JPMorgan Chase & Co. cut their price target on shares of Bath & Body Works from $47.00 to $41.00 and set an “overweight” rating for the company in a report on Monday. Argus reaffirmed a “hold” rating on shares of Bath & Body Works in a research note on Friday, January 10th. Finally, Raymond James cut their target price on shares of Bath & Body Works from $46.00 to $37.00 and set an “outperform” rating for the company in a research note on Thursday. Four analysts have rated the stock with a hold rating and fourteen have issued a buy rating to the company. According to data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $43.13.

Bath & Body Works Stock Up 3.4 %

BBWI stock opened at $28.42 on Friday. Bath & Body Works, Inc. has a twelve month low of $24.96 and a twelve month high of $52.99. The company has a market cap of $6.09 billion, a P/E ratio of 6.93, a PEG ratio of 0.92 and a beta of 1.69. The business has a fifty day moving average of $32.29 and a 200-day moving average of $33.86.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings data on Thursday, February 27th. The company reported $2.09 earnings per share for the quarter, topping the consensus estimate of $2.04 by $0.05. The firm had revenue of $2.79 billion during the quarter, compared to analysts’ expectations of $2.78 billion. Bath & Body Works had a negative return on equity of 44.03% and a net margin of 12.43%. As a group, equities research analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current fiscal year.

Bath & Body Works Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, March 7th. Investors of record on Friday, February 21st were issued a $0.20 dividend. The ex-dividend date was Friday, February 21st. This represents a $0.80 annualized dividend and a yield of 2.81%. Bath & Body Works’s dividend payout ratio is currently 21.98%.

Bath & Body Works announced that its Board of Directors has approved a stock repurchase plan on Thursday, February 27th that allows the company to buyback $500.00 million in shares. This buyback authorization allows the company to reacquire up to 6.4% of its stock through open market purchases. Stock buyback plans are generally a sign that the company’s board believes its stock is undervalued.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.